drugset / Trial / NCT02251210
Efficacy and Safety of BIIL 284 BS in Adult Patients With Active Rheumatoid Arthritis
RandomizedParallel-groupDouble-blindTreatment
Summary
To investigate efficacy and safety of 3 doses of BIIL 284 BS in active rheumatoid arthritis (RA) and determine the dose with most positive efficacy / safety ratio. Pharmacokinetic profile will be also obtained.
Timeline
- Start
- 2001-05
- Primary completion
- 2002-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AMELUBANT | Small molecule | 5 mg | Oral |
| Subject | AMELUBANT | Small molecule | 25 mg | Oral |
| Subject | AMELUBANT | Small molecule | 75 mg | Oral |